Deutsche Bank’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.2M | Buy |
296,899
+58,145
| +24% | +$4.2M | 0.01% | 806 |
|
|
2026
Q1 | $16.3M | Buy |
238,754
+7,486
| +3% | +$530K | 0.01% | 915 |
|
|
2025
Q4 | $17.6M | Buy |
231,268
+151,380
| +189% | +$11M | 0.01% | 905 |
|
|
2025
Q3 | $4.9M | Sell |
79,888
-55,168
| -41% | -$2.87M | ﹤0.01% | 1317 |
|
|
2025
Q2 | $6.6M | Sell |
135,056
-206,668
| -60% | -$9.81M | ﹤0.01% | 1125 |
|
|
2025
Q1 | $17.4M | Buy |
341,724
+247,346
| +262% | +$12.3M | 0.01% | 859 |
|
|
2024
Q4 | $4.26M | Buy |
94,378
+45,310
| +92% | +$1.94M | ﹤0.01% | 1413 |
|
|
2024
Q3 | $1.82M | Buy |
49,068
+10,214
| +26% | +$342K | ﹤0.01% | 1804 |
|
|
2024
Q2 | $1.19M | Sell |
38,854
-5,386
| -12% | -$174K | ﹤0.01% | 1904 |
|
|
2024
Q1 | $1.29M | Buy |
44,240
+7,019
| +19% | +$197K | ﹤0.01% | 1877 |
|
|
2023
Q4 | $1.03M | Sell |
37,221
-160
| -0.4% | -$3.66K | ﹤0.01% | 2012 |
|
|
2023
Q3 | $838K | Buy |
37,381
+5,124
| +16% | +$191K | ﹤0.01% | 1838 |
|
|
2023
Q2 | $1.31M | Sell |
32,257
-15,754
| -33% | -$771K | ﹤0.01% | 1839 |
|
|
2023
Q1 | $2.33M | Sell |
48,011
-14,677
| -23% | -$671K | ﹤0.01% | 1596 |
|
|
2022
Q4 | $2.39M | Sell |
62,688
-70,304
| -53% | -$2.92M | ﹤0.01% | 1553 |
|
|
2022
Q3 | $6.68M | Sell |
132,992
-6,878
| -5% | -$337K | ﹤0.01% | 1107 |
|
|
2022
Q2 | $5.6M | Sell |
139,870
-5,262
| -4% | -$185K | ﹤0.01% | 1231 |
|
|
2022
Q1 | $5.42M | Sell |
145,132
-4,130
| -3% | -$159K | ﹤0.01% | 1383 |
|
|
2021
Q4 | $5.94M | Buy |
149,262
+1,576
| +1% | +$60.3K | ﹤0.01% | 1342 |
|
|
2021
Q3 | $5.5M | Sell |
147,686
-4,943
| -3% | -$203K | ﹤0.01% | 1450 |
|
|
2021
Q2 | $6.45M | Buy |
152,629
+2,384
| +2% | +$102K | ﹤0.01% | 1384 |
|
|
2021
Q1 | $7.11M | Sell |
150,245
-43,782
| -23% | -$2.6M | ﹤0.01% | 1366 |
|
|
2020
Q4 | $11.8M | Buy |
194,027
+14,774
| +8% | +$871K | 0.01% | 967 |
|
|
2020
Q3 | $8.38M | Buy |
179,253
+7,224
| +4% | +$356K | 0.01% | 1034 |
|
|
2020
Q2 | $8.73M | Sell |
172,029
-19,411
| -10% | -$954K | 0.01% | 1030 |
|
|
2020
Q1 | $8.54M | Sell |
191,440
-15,945
| -8% | -$803K | 0.01% | 977 |
|
|
2019
Q4 | $9.96M | Buy |
207,385
+150,187
| +263% | +$6.38M | 0.01% | 1082 |
|
|
2019
Q3 | $1.93M | Sell |
57,198
-182,723
| -76% | -$7.95M | ﹤0.01% | 1937 |
|
|
2019
Q2 | $10.8M | Sell |
239,921
-852,156
| -78% | -$33.7M | 0.01% | 1320 |
|
|
2019
Q1 | $41.1M | Buy |
1,092,077
+113,177
| +12% | +$3.8M | 0.02% | 654 |
|
|
2018
Q4 | $33.6M | Buy |
978,900
+766,443
| +361% | +$27.6M | 0.02% | 650 |
|
|
2018
Q3 | $9.99M | Sell |
212,457
-9,975
| -4% | -$413K | 0.01% | 1635 |
|
|
2018
Q2 | $7.5M | Sell |
222,432
-301,758
| -58% | -$9.41M | ﹤0.01% | 1981 |
|
|
2018
Q1 | $14.2M | Buy |
524,190
+279,732
| +114% | +$7.09M | 0.01% | 1347 |
|
|
2017
Q4 | $4.08M | Buy |
244,458
+184,304
| +306% | +$3.12M | ﹤0.01% | 2178 |
|
|
2017
Q3 | $1.2M | Sell |
60,154
-53,324
| -47% | -$1.04M | ﹤0.01% | 2879 |
|
|
2017
Q2 | $2.08M | Buy |
113,478
+43,638
| +62% | +$588K | ﹤0.01% | 2538 |
|
|
2017
Q1 | $685K | Sell |
69,840
-333,250
| -83% | -$4.03M | ﹤0.01% | 2903 |
|
|
2016
Q4 | $4.39M | Sell |
403,090
-296,983
| -42% | -$3.12M | ﹤0.01% | 1740 |
|
|
2016
Q3 | $9.8M | Buy |
700,073
+531,196
| +315% | +$4.32M | 0.01% | 1319 |
|
|
2016
Q2 | $1.18M | Sell |
168,877
-191,113
| -53% | -$1.4M | ﹤0.01% | 2765 |
|
|
2016
Q1 | $2.32M | Buy |
359,990
+95,708
| +36% | +$1.66M | ﹤0.01% | 2277 |
|
|
2015
Q4 | $8.56M | Sell |
264,282
-200,822
| -43% | -$5.91M | 0.01% | 1426 |
|
|
2015
Q3 | $12.4M | Buy |
465,104
+59,851
| +15% | +$2.56M | 0.01% | 1163 |
|
|
2015
Q2 | $19.5M | Buy |
405,253
+259,153
| +177% | +$15.1M | 0.01% | 942 |
|
|
2015
Q1 | $8.89M | Buy |
146,100
+73,512
| +101% | +$4.49M | 0.01% | 1423 |
|
|
2014
Q4 | $3.76M | Sell |
72,588
-50,839
| -41% | -$2.24M | ﹤0.01% | 2183 |
|
|
2014
Q3 | $5.43M | Buy |
123,427
+65,588
| +113% | +$2.05M | ﹤0.01% | 1763 |
|
|
2014
Q2 | $1.51M | Buy |
57,839
+32,462
| +128% | +$695K | ﹤0.01% | 2640 |
|
|
2014
Q1 | $662K | Sell |
25,377
-38,527
| -60% | -$1.04M | ﹤0.01% | 3139 |
|
|
2013
Q4 | $1.08M | Buy |
63,904
+33,906
| +113% | +$596K | ﹤0.01% | 2611 |
|
|
2013
Q3 | $643K | Buy |
+29,998
| New | +$521K | ﹤0.01% | 3311 |
|
Other funds holding PTCT
RI
JT
Deutsche Bank's PTCT Position: Q2 2026 in Review
Deutsche Bank increased its PTC Therapeutics (PTCT) stake by 24% in Q2 2026, buying an estimated $4.2M and bringing the position to 296,899 shares worth $24.2M. The position accounts for 0.01% of the portfolio, ranked #806.
Deutsche Bank first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. The position peaked at $41.1M in Q1 2019. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Deutsche Bank held 296,899 shares of PTC Therapeutics worth $24.2M as of Q2 2026.
- Deutsche Bank bought 58,145 PTC Therapeutics shares in Q2 2026, an estimated $4.2M.
- PTC Therapeutics made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #806 holding.
- Deutsche Bank first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
- Deutsche Bank's PTC Therapeutics position peaked at $41.1M in Q1 2019.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.